ChatGPT is only so-so at letting physicians know if any given clinical study is relevant to their patient rosters and, as such, deserving of a full, time-consuming read. On the other hand ...
Imperfect algorithms. Resistant clinicians. Wary patients. Divisive disparities. The plot ingredients of a flashy techno-thriller coming to a cineplex near you? No—just a few of the many worries that provider organizations take on when they move to adopt AI at scale.
Notching its fifth go-ahead from the FDA, an Israel-based AI startup has received the agency’s 510(k) clearance to market software that automatically identifies signs of compression fractures in the spine.
A new scientific statement from the American Heart Association explores the many ways AI and machine learning are being used to improve care for heart patients.